Related references
Note: Only part of the references are listed.Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?
Mrinalini Dey et al.
RHEUMATOLOGY (2023)
Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs
Hironari Hanaoka et al.
CLINICAL KIDNEY JOURNAL (2022)
KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE
Ian H. de Boer et al.
KIDNEY INTERNATIONAL (2022)
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States
Rahul Raiker et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis
Edmund Y. M. Chung et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
Brandon Michael Henry et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)
Renal dysfunction among rheumatoid arthritis patients: A retrospective cohort study
Ashraf O. Oweis et al.
ANNALS OF MEDICINE AND SURGERY (2020)
End-stage renal disease in patients with rheumatoid arthritis
Sunita Paudyal et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals
Shunsuke Mori et al.
CLINICAL RHEUMATOLOGY (2017)
The Prevalence and Management of Systemic Amyloidosis in Western Countries
Hans L. A. Nienhuis et al.
KIDNEY DISEASES (2016)
Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward
Adeera Levin et al.
KIDNEY INTERNATIONAL (2014)
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
Paul E. Stevens et al.
ANNALS OF INTERNAL MEDICINE (2013)
A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis
Muhammad Haroon et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2011)
Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis
Tadashi Nakamura et al.
CLINICAL RHEUMATOLOGY (2010)
Susceptibility to AA Amyloidosis in Rheumatic Diseases: A Critical Overview
Laura Obici et al.
ARTHRITIS CARE & RESEARCH (2009)
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
Jasvinder A. Singh et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study
K. Karstila et al.
CLINICAL RHEUMATOLOGY (2007)
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study
K. Yamagata et al.
KIDNEY INTERNATIONAL (2007)
A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal
EHS Choy et al.
RHEUMATOLOGY (2005)
Share Paper
